BRYNJELSEN SEAN
Insider CIK 1669976 · SGNT EVP, Business Development · ETON President & CEO, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ETON Eton Pharmaceuticals, Inc. | S Sale | 2026-08-20 | 2026-08-20 | 47,307 | $60.17 | $2.85M | 1,004,909 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | S Sale | 2026-08-20 | 2026-08-20 | 36,373 | $61.11 | $2.22M | 968,536 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | S Sale | 2026-08-20 | 2026-08-20 | 7,342 | $62.12 | $456.1K | 961,194 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | S Sale | 2026-08-20 | 2026-08-20 | 7,342 | $62.12 | $456.1K | 961,194 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | S Sale | 2026-08-20 | 2026-08-20 | 36,373 | $61.11 | $2.22M | 968,536 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | S Sale | 2026-08-20 | 2026-08-20 | 47,307 | $60.17 | $2.85M | 1,004,909 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | S Sale | 2026-08-19 | 2026-08-20 | 8,978 | $62.65 | $562.5K | 1,052,216 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | S Sale | 2026-08-19 | 2026-08-20 | 8,978 | $62.65 | $562.5K | 1,052,216 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2026-07-31 | 2026-08-04 | 128,985 | — | $0 | 128,985 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2026-07-31 | 2026-08-04 | 128,985 | — | $0 | 128,985 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | M Exercise deriv | 2026-07-14 | 2026-07-14 | 200,000 | — | $0 | 0 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | M Exercise | 2026-07-14 | 2026-07-14 | 200,000 | $1.37 | $274.0K | 1,061,194 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | M Exercise deriv | 2026-07-12 | 2026-07-14 | 27,500 | — | $0 | 0 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | M Exercise | 2026-07-12 | 2026-07-14 | 27,500 | — | $0 | 861,194 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | S Sale | 2026-05-28 | 2026-05-29 | 119,852 | $31.88 | $3.82M | 833,842 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | S Sale | 2026-05-28 | 2026-05-29 | 148 | $32.67 | $4.8K | 833,694 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2026-01-12 | 2026-01-14 | 158,046 | — | $0 | 3,047,312 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2026-01-12 | 2026-01-14 | 100,517 | — | $0 | 3,147,829 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | F Tax w/h | 2026-01-01 | 2026-01-14 | 5,015 | $15.39 | $77.2K | 2,889,266 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | F Tax w/h | 2025-12-12 | 2025-12-12 | 6,732 | $16.83 | $113.3K | 2,894,281 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | S Sale | 2025-06-05 | 2025-06-05 | 70,000 | $16.81 | $1.18M | 2,873,513 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | S Sale | 2025-06-04 | 2025-06-05 | 70,000 | $17.00 | $1.19M | 2,943,513 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | S Sale | 2025-06-03 | 2025-06-05 | 400 | $19.02 | $7.6K | 3,013,513 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | S Sale | 2025-06-03 | 2025-06-05 | 60,945 | $17.38 | $1.06M | 3,022,568 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | S Sale | 2025-06-03 | 2025-06-05 | 8,655 | $18.38 | $159.1K | 3,013,913 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2025-01-03 | 2025-01-06 | 107,469 | — | $0 | 107,469 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2025-01-03 | 2025-01-06 | 72,004 | — | $0 | 72,004 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2024-02-13 | 2024-02-15 | 438,633 | — | $0 | 2,473,014 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2023-03-03 | 2023-03-03 | 350,381 | — | $0 | 1,951,881 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | P Buy | 2022-09-22 | 2022-09-23 | 10,000 | $2.10 | $21.0K | 1,040,000 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2022-07-12 | 2022-07-18 | 110,000 | — | $0 | 110,000 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2022-02-07 | 2022-02-28 | 416,500 | — | $0 | 1,601,500 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | P Buy | 2021-08-20 | 2021-08-20 | 10,000 | $4.32 | $43.2K | 1,030,000 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | P Buy | 2021-06-03 | 2021-06-03 | 5,000 | $5.96 | $29.8K | 1,030,000 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2021-05-03 | 2021-05-05 | 245,000 | — | $0 | 1,185,000 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2020-03-12 | 2020-03-16 | 490,000 | — | $0 | 490,000 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | P Buy | 2019-08-13 | 2019-08-13 | 5,000 | $6.15 | $30.8K | 1,025,000 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | P Buy | 2019-05-21 | 2019-05-22 | 8,600 | $7.96 | $68.5K | 1,020,000 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | P Buy | 2019-05-20 | 2019-05-22 | 1,400 | $7.78 | $10.9K | 1,011,400 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2019-02-20 | 2019-03-08 | 250,000 | — | $0 | 250,000 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | C Conversion deriv | 2018-11-15 | 2018-11-15 | 23,000 | — | $0 | 0 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | P Buy | 2018-11-15 | 2018-11-15 | 10,000 | $6.00 | $60.0K | 1,010,000 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | C Conversion | 2018-11-15 | 2018-11-15 | 24,940 | — | $0 | 24,940 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | D To issuer deriv | 2016-08-29 | 2016-08-31 | 21,016 | $9.56 | $200.9K | 0 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | D To issuer | 2016-08-29 | 2016-08-31 | 9,844 | $21.75 | $214.1K | 0 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award deriv | 2016-04-04 | 2016-04-06 | 21,016 | — | $0 | 21,016 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award | 2016-04-04 | 2016-04-06 | 9,844 | — | $0 | 9,844 | SEC↗ |